 | Up a level |
Everts-Graber, Judith; Bonel, Harald; Lehmann, Daniel; Gahl, Brigitta; Häuselmann, HansJörg; Studer, Ueli; Ziswiler, Hans-Rudolf; Reichenbach, Stephan; Lehmann, Thomas (2023). Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study. Osteoporosis international, 34(11), pp. 1961-1973. Springer-Verlag 10.1007/s00198-023-06863-y
Everts-Graber, Judith; Bonel, Harald; Lehmann, Daniel; Gahl, Brigitta; Häuselmann, HansJörg; Studer, Ueli; Ziswiler, Hans-Rudolf; Reichenbach, Stephan; Lehmann, Thomas (2023). Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study. Osteoporosis international, 34(11), p. 1975. Springer-Verlag 10.1007/s00198-023-06887-4
Everts-Graber, Judith; Bonel, Harald; Lehmann, Daniel; Gahl, Brigitta; Häuselmann, HansJörg; Studer, Ueli; Ziswiler, Hans-Rudolf; Reichenbach, Stephan; Lehmann, Thomas (2022). Incidence of Atypical Femoral Fractures in Patients on Osteoporosis Therapy-A Registry-Based Cohort Study. JBMR plus, 6(10), e10681. Wiley 10.1002/jbm4.10681
Everts-Graber, Judith; Lehmann, Daniel; Burkhard, John Patrik Matthias; Schaller, Benoît; Gahl, Brigitta; Häuselmann, HansJörg; Studer, Ueli; Ziswiler, Hans-Rudolf; Reichenbach, Stephan; Lehmann, Thomas (2022). Risk of Osteonecrosis of the Jaw Under Denosumab Compared to Bisphosphonates in Patients With Osteoporosis. Journal of bone and mineral research, 37(2), pp. 340-348. Wiley-Blackwell 10.1002/jbmr.4472
